Surface Polyethylene Glycol Nanoliposome-encapsulated microRNA-495-3p Regulates mTOR Pathway and Improves Immune Cell Function in Colon Cancer Through Targeting GXYLT1 Article Swipe
Liquan Cai
,
Jiangrong Chen
,
Chang Wen Ke
,
Baiping Zhang
,
Yuqing Xiong
,
H. Y. Fu
·
YOU?
·
· 2025
· Open Access
·
· DOI: https://doi.org/10.1177/09731296251371482
YOU?
·
· 2025
· Open Access
·
· DOI: https://doi.org/10.1177/09731296251371482
Background miR-495-3p expression is related to tumor pathogenesis. Purpose This study explores the mechanism of the protective role of miR-495-3p in colon cancer and its interaction with glucoside xylosyltransferase 1 (GXYLT1) and mammalian target of rapamycin (mTOR) pathway. Materials and Methods A rat model of colon cancer was treated with polyethylene glycol (PEG) nanoliposomes, miR-495-3p, miR-495-3p-loaded PEG nanoliposomes, mTOR agonist, and mTOR inhibitor. After 1 week of intervention, rat colon tissues were taken for hematoxylin and eosin (HE) staining to identify the function of miR-495-3p-loaded PEG nanoliposomes on inflammation and gene expression was detected. Results miR-495-3p-loaded PEG nanoliposomes significantly inhibited cell proliferation and migration and had the lowest degree of infiltration and mitosis ( p < .05). The addition of mTOR inhibitors further amplified the effect of miR-495-3p-loaded PEG nanoliposomes. Compared with miR-495-3p-loaded PEG nanoliposomes group, the GXYLT1 knockout + miR-495-3p-loaded PEG nanoliposomes had higher mTOR expression, and the addition of mTOR inhibitors decreased the level of mTOR ( p < .05). Conclusion Encapsulation of miR-495-3p in PEG nanoliposomes can help enhance its targeting effect on colon cancer and improve the function of immune cells by inhibiting the level of GXYLT1 through regulation of the mTOR pathway. These findings provide a novel insight into nanoparticle-based gene therapy of colon cancer.
Related Topics
Concepts
No concepts available.
Metadata
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.1177/09731296251371482
- https://journals.sagepub.com/doi/pdf/10.1177/09731296251371482
- OA Status
- hybrid
- References
- 33
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4414128366
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4414128366Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1177/09731296251371482Digital Object Identifier
- Title
-
Surface Polyethylene Glycol Nanoliposome-encapsulated microRNA-495-3p Regulates mTOR Pathway and Improves Immune Cell Function in Colon Cancer Through Targeting GXYLT1Work title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2025Year of publication
- Publication date
-
2025-09-11Full publication date if available
- Authors
-
Liquan Cai, Jiangrong Chen, Chang Wen Ke, Baiping Zhang, Yuqing Xiong, H. Y. FuList of authors in order
- Landing page
-
https://doi.org/10.1177/09731296251371482Publisher landing page
- PDF URL
-
https://journals.sagepub.com/doi/pdf/10.1177/09731296251371482Direct link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
hybridOpen access status per OpenAlex
- OA URL
-
https://journals.sagepub.com/doi/pdf/10.1177/09731296251371482Direct OA link when available
- Cited by
-
0Total citation count in OpenAlex
- References (count)
-
33Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4414128366 |
|---|---|
| doi | https://doi.org/10.1177/09731296251371482 |
| ids.doi | https://doi.org/10.1177/09731296251371482 |
| ids.openalex | https://openalex.org/W4414128366 |
| fwci | 0.0 |
| type | article |
| title | Surface Polyethylene Glycol Nanoliposome-encapsulated microRNA-495-3p Regulates mTOR Pathway and Improves Immune Cell Function in Colon Cancer Through Targeting GXYLT1 |
| biblio.issue | |
| biblio.volume | |
| biblio.last_page | |
| biblio.first_page | |
| topics[0].id | https://openalex.org/T10062 |
| topics[0].field.id | https://openalex.org/fields/13 |
| topics[0].field.display_name | Biochemistry, Genetics and Molecular Biology |
| topics[0].score | 0.9976999759674072 |
| topics[0].domain.id | https://openalex.org/domains/1 |
| topics[0].domain.display_name | Life Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/1306 |
| topics[0].subfield.display_name | Cancer Research |
| topics[0].display_name | MicroRNA in disease regulation |
| topics[1].id | https://openalex.org/T11482 |
| topics[1].field.id | https://openalex.org/fields/13 |
| topics[1].field.display_name | Biochemistry, Genetics and Molecular Biology |
| topics[1].score | 0.9934999942779541 |
| topics[1].domain.id | https://openalex.org/domains/1 |
| topics[1].domain.display_name | Life Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/1312 |
| topics[1].subfield.display_name | Molecular Biology |
| topics[1].display_name | RNA modifications and cancer |
| topics[2].id | https://openalex.org/T12387 |
| topics[2].field.id | https://openalex.org/fields/24 |
| topics[2].field.display_name | Immunology and Microbiology |
| topics[2].score | 0.9932000041007996 |
| topics[2].domain.id | https://openalex.org/domains/1 |
| topics[2].domain.display_name | Life Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2403 |
| topics[2].subfield.display_name | Immunology |
| topics[2].display_name | Galectins and Cancer Biology |
| is_xpac | False |
| apc_list | |
| apc_paid | |
| language | en |
| locations[0].id | doi:10.1177/09731296251371482 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S40318847 |
| locations[0].source.issn | 0973-1296, 0976-4062 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | False |
| locations[0].source.issn_l | 0973-1296 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | False |
| locations[0].source.display_name | Pharmacognosy Magazine |
| locations[0].source.host_organization | https://openalex.org/P4310320017 |
| locations[0].source.host_organization_name | SAGE Publishing |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310320017 |
| locations[0].license | cc-by-nc |
| locations[0].pdf_url | https://journals.sagepub.com/doi/pdf/10.1177/09731296251371482 |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | https://openalex.org/licenses/cc-by-nc |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Pharmacognosy Magazine |
| locations[0].landing_page_url | https://doi.org/10.1177/09731296251371482 |
| indexed_in | crossref |
| authorships[0].author.id | https://openalex.org/A5047186824 |
| authorships[0].author.orcid | https://orcid.org/0000-0001-9192-2673 |
| authorships[0].author.display_name | Liquan Cai |
| authorships[0].countries | CN |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I4210093739 |
| authorships[0].affiliations[0].raw_affiliation_string | Department of Preventive Medicine, School of Clinical Medicine, Jiangxi Medical College, Shangrao, Jiangxi, China |
| authorships[0].institutions[0].id | https://openalex.org/I4210093739 |
| authorships[0].institutions[0].ror | https://ror.org/00g3pqv36 |
| authorships[0].institutions[0].type | healthcare |
| authorships[0].institutions[0].lineage | https://openalex.org/I4210093739 |
| authorships[0].institutions[0].country_code | CN |
| authorships[0].institutions[0].display_name | First Affiliated Hospital of Jiangxi Medical College |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Lingqing Cai |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | Department of Preventive Medicine, School of Clinical Medicine, Jiangxi Medical College, Shangrao, Jiangxi, China |
| authorships[1].author.id | https://openalex.org/A5011664227 |
| authorships[1].author.orcid | |
| authorships[1].author.display_name | Jiangrong Chen |
| authorships[1].countries | CN |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I4210093739 |
| authorships[1].affiliations[0].raw_affiliation_string | Department of Diagnostics Teaching and Research, School of Clinical Medicine, Jiangxi Medical College, Shangrao, Jiangxi, China |
| authorships[1].institutions[0].id | https://openalex.org/I4210093739 |
| authorships[1].institutions[0].ror | https://ror.org/00g3pqv36 |
| authorships[1].institutions[0].type | healthcare |
| authorships[1].institutions[0].lineage | https://openalex.org/I4210093739 |
| authorships[1].institutions[0].country_code | CN |
| authorships[1].institutions[0].display_name | First Affiliated Hospital of Jiangxi Medical College |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Jiangrong Chen |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Department of Diagnostics Teaching and Research, School of Clinical Medicine, Jiangxi Medical College, Shangrao, Jiangxi, China |
| authorships[2].author.id | https://openalex.org/A5047965463 |
| authorships[2].author.orcid | https://orcid.org/0000-0002-2178-7557 |
| authorships[2].author.display_name | Chang Wen Ke |
| authorships[2].countries | CN |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I4210104439, https://openalex.org/I4210160531 |
| authorships[2].affiliations[0].raw_affiliation_string | Department of Oncology, the 908th Hospital of Chinese People's Liberation Army Joint Logistic Support Force, Nanchang, Jiangxi, China |
| authorships[2].institutions[0].id | https://openalex.org/I4210160531 |
| authorships[2].institutions[0].ror | https://ror.org/05tf9r976 |
| authorships[2].institutions[0].type | government |
| authorships[2].institutions[0].lineage | https://openalex.org/I4210160531 |
| authorships[2].institutions[0].country_code | CN |
| authorships[2].institutions[0].display_name | Chinese People's Liberation Army |
| authorships[2].institutions[1].id | https://openalex.org/I4210104439 |
| authorships[2].institutions[1].ror | https://ror.org/01cnyad13 |
| authorships[2].institutions[1].type | healthcare |
| authorships[2].institutions[1].lineage | https://openalex.org/I4210104439 |
| authorships[2].institutions[1].country_code | CN |
| authorships[2].institutions[1].display_name | People's Liberation Army 401 Hospital |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Chuanqing Ke |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Department of Oncology, the 908th Hospital of Chinese People's Liberation Army Joint Logistic Support Force, Nanchang, Jiangxi, China |
| authorships[3].author.id | https://openalex.org/A5000729930 |
| authorships[3].author.orcid | |
| authorships[3].author.display_name | Baiping Zhang |
| authorships[3].countries | CN |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I4210104439, https://openalex.org/I4210160531 |
| authorships[3].affiliations[0].raw_affiliation_string | Department of Clinic, the 908th Hospital of Chinese People's Liberation Army Joint Logistic Support Force, Nanchang, Jiangxi, China |
| authorships[3].institutions[0].id | https://openalex.org/I4210160531 |
| authorships[3].institutions[0].ror | https://ror.org/05tf9r976 |
| authorships[3].institutions[0].type | government |
| authorships[3].institutions[0].lineage | https://openalex.org/I4210160531 |
| authorships[3].institutions[0].country_code | CN |
| authorships[3].institutions[0].display_name | Chinese People's Liberation Army |
| authorships[3].institutions[1].id | https://openalex.org/I4210104439 |
| authorships[3].institutions[1].ror | https://ror.org/01cnyad13 |
| authorships[3].institutions[1].type | healthcare |
| authorships[3].institutions[1].lineage | https://openalex.org/I4210104439 |
| authorships[3].institutions[1].country_code | CN |
| authorships[3].institutions[1].display_name | People's Liberation Army 401 Hospital |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Baiping Zhang |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Department of Clinic, the 908th Hospital of Chinese People's Liberation Army Joint Logistic Support Force, Nanchang, Jiangxi, China |
| authorships[4].author.id | https://openalex.org/A5020962054 |
| authorships[4].author.orcid | https://orcid.org/0000-0002-3222-6691 |
| authorships[4].author.display_name | Yuqing Xiong |
| authorships[4].countries | CN |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I4210104439, https://openalex.org/I4210160531 |
| authorships[4].affiliations[0].raw_affiliation_string | Department of First Resident Outpatient, the 908th Hospital of Chinese People's Liberation Army Joint Logistic Support Force, Nanchang, Jiangxi, China |
| authorships[4].institutions[0].id | https://openalex.org/I4210160531 |
| authorships[4].institutions[0].ror | https://ror.org/05tf9r976 |
| authorships[4].institutions[0].type | government |
| authorships[4].institutions[0].lineage | https://openalex.org/I4210160531 |
| authorships[4].institutions[0].country_code | CN |
| authorships[4].institutions[0].display_name | Chinese People's Liberation Army |
| authorships[4].institutions[1].id | https://openalex.org/I4210104439 |
| authorships[4].institutions[1].ror | https://ror.org/01cnyad13 |
| authorships[4].institutions[1].type | healthcare |
| authorships[4].institutions[1].lineage | https://openalex.org/I4210104439 |
| authorships[4].institutions[1].country_code | CN |
| authorships[4].institutions[1].display_name | People's Liberation Army 401 Hospital |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Yuqing Xiong |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | Department of First Resident Outpatient, the 908th Hospital of Chinese People's Liberation Army Joint Logistic Support Force, Nanchang, Jiangxi, China |
| authorships[5].author.id | https://openalex.org/A5114027663 |
| authorships[5].author.orcid | https://orcid.org/0000-0001-5888-9373 |
| authorships[5].author.display_name | H. Y. Fu |
| authorships[5].countries | CN |
| authorships[5].affiliations[0].institution_ids | https://openalex.org/I4210104439, https://openalex.org/I4210160531 |
| authorships[5].affiliations[0].raw_affiliation_string | Department of Oncology, the 908th Hospital of Chinese People's Liberation Army Joint Logistic Support Force, Nanchang, Jiangxi, China |
| authorships[5].institutions[0].id | https://openalex.org/I4210160531 |
| authorships[5].institutions[0].ror | https://ror.org/05tf9r976 |
| authorships[5].institutions[0].type | government |
| authorships[5].institutions[0].lineage | https://openalex.org/I4210160531 |
| authorships[5].institutions[0].country_code | CN |
| authorships[5].institutions[0].display_name | Chinese People's Liberation Army |
| authorships[5].institutions[1].id | https://openalex.org/I4210104439 |
| authorships[5].institutions[1].ror | https://ror.org/01cnyad13 |
| authorships[5].institutions[1].type | healthcare |
| authorships[5].institutions[1].lineage | https://openalex.org/I4210104439 |
| authorships[5].institutions[1].country_code | CN |
| authorships[5].institutions[1].display_name | People's Liberation Army 401 Hospital |
| authorships[5].author_position | last |
| authorships[5].raw_author_name | Huiying Fu |
| authorships[5].is_corresponding | True |
| authorships[5].raw_affiliation_strings | Department of Oncology, the 908th Hospital of Chinese People's Liberation Army Joint Logistic Support Force, Nanchang, Jiangxi, China |
| has_content.pdf | True |
| has_content.grobid_xml | False |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://journals.sagepub.com/doi/pdf/10.1177/09731296251371482 |
| open_access.oa_status | hybrid |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Surface Polyethylene Glycol Nanoliposome-encapsulated microRNA-495-3p Regulates mTOR Pathway and Improves Immune Cell Function in Colon Cancer Through Targeting GXYLT1 |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T10062 |
| primary_topic.field.id | https://openalex.org/fields/13 |
| primary_topic.field.display_name | Biochemistry, Genetics and Molecular Biology |
| primary_topic.score | 0.9976999759674072 |
| primary_topic.domain.id | https://openalex.org/domains/1 |
| primary_topic.domain.display_name | Life Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/1306 |
| primary_topic.subfield.display_name | Cancer Research |
| primary_topic.display_name | MicroRNA in disease regulation |
| related_works | https://openalex.org/W2332336499, https://openalex.org/W2905499538, https://openalex.org/W2313903280, https://openalex.org/W2356915299, https://openalex.org/W2037651561, https://openalex.org/W2064730869, https://openalex.org/W2322734595, https://openalex.org/W2344334204, https://openalex.org/W1966490926, https://openalex.org/W4405954108 |
| cited_by_count | 0 |
| locations_count | 1 |
| best_oa_location.id | doi:10.1177/09731296251371482 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S40318847 |
| best_oa_location.source.issn | 0973-1296, 0976-4062 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | False |
| best_oa_location.source.issn_l | 0973-1296 |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | False |
| best_oa_location.source.display_name | Pharmacognosy Magazine |
| best_oa_location.source.host_organization | https://openalex.org/P4310320017 |
| best_oa_location.source.host_organization_name | SAGE Publishing |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310320017 |
| best_oa_location.license | cc-by-nc |
| best_oa_location.pdf_url | https://journals.sagepub.com/doi/pdf/10.1177/09731296251371482 |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by-nc |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | Pharmacognosy Magazine |
| best_oa_location.landing_page_url | https://doi.org/10.1177/09731296251371482 |
| primary_location.id | doi:10.1177/09731296251371482 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S40318847 |
| primary_location.source.issn | 0973-1296, 0976-4062 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | False |
| primary_location.source.issn_l | 0973-1296 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | False |
| primary_location.source.display_name | Pharmacognosy Magazine |
| primary_location.source.host_organization | https://openalex.org/P4310320017 |
| primary_location.source.host_organization_name | SAGE Publishing |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310320017 |
| primary_location.license | cc-by-nc |
| primary_location.pdf_url | https://journals.sagepub.com/doi/pdf/10.1177/09731296251371482 |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | https://openalex.org/licenses/cc-by-nc |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Pharmacognosy Magazine |
| primary_location.landing_page_url | https://doi.org/10.1177/09731296251371482 |
| publication_date | 2025-09-11 |
| publication_year | 2025 |
| referenced_works | https://openalex.org/W2800329306, https://openalex.org/W4318617166, https://openalex.org/W4318065400, https://openalex.org/W4317387905, https://openalex.org/W4328053360, https://openalex.org/W4317708732, https://openalex.org/W3115098237, https://openalex.org/W4281389944, https://openalex.org/W4320485268, https://openalex.org/W3081598261, https://openalex.org/W4361224331, https://openalex.org/W4283585922, https://openalex.org/W4313245749, https://openalex.org/W4311804200, https://openalex.org/W4225744358, https://openalex.org/W4362497854, https://openalex.org/W2992633593, https://openalex.org/W4220664593, https://openalex.org/W4322628833, https://openalex.org/W4319662249, https://openalex.org/W4362584029, https://openalex.org/W4224218456, https://openalex.org/W4320709406, https://openalex.org/W4361274181, https://openalex.org/W4319598347, https://openalex.org/W4321457409, https://openalex.org/W4318929186, https://openalex.org/W4319335559, https://openalex.org/W4362737923, https://openalex.org/W4362731402, https://openalex.org/W4361001263, https://openalex.org/W4283370233, https://openalex.org/W4287267565 |
| referenced_works_count | 33 |
| abstract_inverted_index.( | 113, 158 |
| abstract_inverted_index.+ | 139 |
| abstract_inverted_index.1 | 29, 64 |
| abstract_inverted_index.A | 41 |
| abstract_inverted_index.a | 200 |
| abstract_inverted_index.p | 114, 159 |
| abstract_inverted_index.by | 185 |
| abstract_inverted_index.in | 20, 166 |
| abstract_inverted_index.is | 3 |
| abstract_inverted_index.of | 14, 18, 34, 44, 66, 83, 109, 119, 126, 150, 156, 164, 182, 189, 193, 207 |
| abstract_inverted_index.on | 87, 175 |
| abstract_inverted_index.to | 5, 79 |
| abstract_inverted_index.PEG | 56, 85, 96, 128, 133, 141, 167 |
| abstract_inverted_index.The | 117 |
| abstract_inverted_index.and | 23, 31, 39, 60, 75, 89, 102, 104, 111, 147, 178 |
| abstract_inverted_index.can | 169 |
| abstract_inverted_index.for | 73 |
| abstract_inverted_index.had | 105, 143 |
| abstract_inverted_index.its | 24, 172 |
| abstract_inverted_index.rat | 42, 68 |
| abstract_inverted_index.the | 12, 15, 81, 106, 124, 136, 148, 154, 180, 187, 194 |
| abstract_inverted_index.was | 47, 92 |
| abstract_inverted_index.< | 115, 160 |
| abstract_inverted_index.(HE) | 77 |
| abstract_inverted_index.This | 9 |
| abstract_inverted_index.cell | 100 |
| abstract_inverted_index.gene | 90, 205 |
| abstract_inverted_index.help | 170 |
| abstract_inverted_index.into | 203 |
| abstract_inverted_index.mTOR | 58, 61, 120, 145, 151, 157, 195 |
| abstract_inverted_index.role | 17 |
| abstract_inverted_index.week | 65 |
| abstract_inverted_index.were | 71 |
| abstract_inverted_index.with | 26, 49, 131 |
| abstract_inverted_index.(PEG) | 52 |
| abstract_inverted_index..05). | 116, 161 |
| abstract_inverted_index.After | 63 |
| abstract_inverted_index.These | 197 |
| abstract_inverted_index.cells | 184 |
| abstract_inverted_index.colon | 21, 45, 69, 176, 208 |
| abstract_inverted_index.eosin | 76 |
| abstract_inverted_index.level | 155, 188 |
| abstract_inverted_index.model | 43 |
| abstract_inverted_index.novel | 201 |
| abstract_inverted_index.study | 10 |
| abstract_inverted_index.taken | 72 |
| abstract_inverted_index.tumor | 6 |
| abstract_inverted_index.(mTOR) | 36 |
| abstract_inverted_index.GXYLT1 | 137, 190 |
| abstract_inverted_index.cancer | 22, 46, 177 |
| abstract_inverted_index.degree | 108 |
| abstract_inverted_index.effect | 125, 174 |
| abstract_inverted_index.glycol | 51 |
| abstract_inverted_index.group, | 135 |
| abstract_inverted_index.higher | 144 |
| abstract_inverted_index.immune | 183 |
| abstract_inverted_index.lowest | 107 |
| abstract_inverted_index.target | 33 |
| abstract_inverted_index.Methods | 40 |
| abstract_inverted_index.Purpose | 8 |
| abstract_inverted_index.Results | 94 |
| abstract_inverted_index.cancer. | 209 |
| abstract_inverted_index.enhance | 171 |
| abstract_inverted_index.further | 122 |
| abstract_inverted_index.improve | 179 |
| abstract_inverted_index.insight | 202 |
| abstract_inverted_index.mitosis | 112 |
| abstract_inverted_index.provide | 199 |
| abstract_inverted_index.related | 4 |
| abstract_inverted_index.therapy | 206 |
| abstract_inverted_index.through | 191 |
| abstract_inverted_index.tissues | 70 |
| abstract_inverted_index.treated | 48 |
| abstract_inverted_index.(GXYLT1) | 30 |
| abstract_inverted_index.Compared | 130 |
| abstract_inverted_index.addition | 118, 149 |
| abstract_inverted_index.agonist, | 59 |
| abstract_inverted_index.explores | 11 |
| abstract_inverted_index.findings | 198 |
| abstract_inverted_index.function | 82, 181 |
| abstract_inverted_index.identify | 80 |
| abstract_inverted_index.knockout | 138 |
| abstract_inverted_index.pathway. | 37, 196 |
| abstract_inverted_index.staining | 78 |
| abstract_inverted_index.Materials | 38 |
| abstract_inverted_index.amplified | 123 |
| abstract_inverted_index.decreased | 153 |
| abstract_inverted_index.detected. | 93 |
| abstract_inverted_index.glucoside | 27 |
| abstract_inverted_index.inhibited | 99 |
| abstract_inverted_index.mammalian | 32 |
| abstract_inverted_index.mechanism | 13 |
| abstract_inverted_index.migration | 103 |
| abstract_inverted_index.rapamycin | 35 |
| abstract_inverted_index.targeting | 173 |
| abstract_inverted_index.Background | 0 |
| abstract_inverted_index.Conclusion | 162 |
| abstract_inverted_index.expression | 2, 91 |
| abstract_inverted_index.inhibiting | 186 |
| abstract_inverted_index.inhibitor. | 62 |
| abstract_inverted_index.inhibitors | 121, 152 |
| abstract_inverted_index.miR-495-3p | 1, 19, 165 |
| abstract_inverted_index.protective | 16 |
| abstract_inverted_index.regulation | 192 |
| abstract_inverted_index.expression, | 146 |
| abstract_inverted_index.hematoxylin | 74 |
| abstract_inverted_index.interaction | 25 |
| abstract_inverted_index.miR-495-3p, | 54 |
| abstract_inverted_index.infiltration | 110 |
| abstract_inverted_index.inflammation | 88 |
| abstract_inverted_index.polyethylene | 50 |
| abstract_inverted_index.Encapsulation | 163 |
| abstract_inverted_index.intervention, | 67 |
| abstract_inverted_index.nanoliposomes | 86, 97, 134, 142, 168 |
| abstract_inverted_index.pathogenesis. | 7 |
| abstract_inverted_index.proliferation | 101 |
| abstract_inverted_index.significantly | 98 |
| abstract_inverted_index.nanoliposomes, | 53, 57 |
| abstract_inverted_index.nanoliposomes. | 129 |
| abstract_inverted_index.miR-495-3p-loaded | 55, 84, 95, 127, 132, 140 |
| abstract_inverted_index.nanoparticle-based | 204 |
| abstract_inverted_index.xylosyltransferase | 28 |
| cited_by_percentile_year | |
| corresponding_author_ids | https://openalex.org/A5114027663 |
| countries_distinct_count | 1 |
| institutions_distinct_count | 6 |
| corresponding_institution_ids | https://openalex.org/I4210104439, https://openalex.org/I4210160531 |
| citation_normalized_percentile.value | 0.49852077 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |